tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

FULC Stock Latest News

Fulcrum data shows clear dose response with pociredir, says Cantor Fitzgerald
The FlyFulcrum data shows clear dose response with pociredir, says Cantor Fitzgerald
1M ago
FULC
Fulcrum Therapeutics Highlights Progress in Sickle Cell Treatment
PremiumCompany Announcements
Fulcrum Therapeutics Highlights Progress in Sickle Cell Treatment
1M ago
8K
FULC
Fulcrum Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Fulcrum Therapeutics Reports Q2 2025 Financial Results
2M ago
FULC
Promising Potential of Fulcrum Therapeutics’ Pociredir: A Buy Rating Backed by Positive Phase 1b Study Results
PremiumRatings
Promising Potential of Fulcrum Therapeutics’ Pociredir: A Buy Rating Backed by Positive Phase 1b Study Results
2M ago
FULC
Buy Rating for Fulcrum Therapeutics: Promising Potential of Pociredir in Sickle Cell Disease Treatment
PremiumRatings
Buy Rating for Fulcrum Therapeutics: Promising Potential of Pociredir in Sickle Cell Disease Treatment
2M ago
FULC
H.C. Wainwright upgrades Fulcrum to Buy on sickle cell data
PremiumThe FlyH.C. Wainwright upgrades Fulcrum to Buy on sickle cell data
2M ago
FULC
Fulcrum Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
Premium
The Fly
Fulcrum Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
2M ago
FULC
Fulcrum Therapeutics price target raised to $15 from $12 at Oppenheimer
Premium
The Fly
Fulcrum Therapeutics price target raised to $15 from $12 at Oppenheimer
2M ago
FULC
Fulcrum Therapeutics Announces Promising Phase 1b Trial Results
PremiumCompany Announcements
Fulcrum Therapeutics Announces Promising Phase 1b Trial Results
2M ago
8K
FULC
Fulcrum Therapeutics’ pociredir shows efficacy in sickle cell disease
PremiumThe Fly
Fulcrum Therapeutics’ pociredir shows efficacy in sickle cell disease
2M ago
FULC
Fulcrum Therapeutics reports Q2 EPS (28c), consensus (29c)
PremiumThe Fly
Fulcrum Therapeutics reports Q2 EPS (28c), consensus (29c)
2M ago
FULC
Fulcrum Therapeutics initiated with Early-Stage Biotech at Goldman Sachs
PremiumThe Fly
Fulcrum Therapeutics initiated with Early-Stage Biotech at Goldman Sachs
3M ago
FULC
Fulcrum Therapeutics price target raised to $6 from $2 at BofA
PremiumThe FlyFulcrum Therapeutics price target raised to $6 from $2 at BofA
3M ago
FULC
Cautious Outlook on Fulcrum Therapeutics Amid Safety Concerns and Narrowed Trial Focus
Premium
Ratings
Cautious Outlook on Fulcrum Therapeutics Amid Safety Concerns and Narrowed Trial Focus
3M ago
FULC
Fulcrum Therapeutics Elects New Directors at Annual Meeting
Premium
Company Announcements
Fulcrum Therapeutics Elects New Directors at Annual Meeting
3M ago
8K
FULC
Fulcrum Therapeutics price target raised to $9 from $6 at Piper Sandler
PremiumThe Fly
Fulcrum Therapeutics price target raised to $9 from $6 at Piper Sandler
4M ago
FULC
Stocks slide as Trump threatens new tariffs against EU and Apple: Morning Buzz
PremiumThe Fly
Stocks slide as Trump threatens new tariffs against EU and Apple: Morning Buzz
5M ago
X
BAH
Fulcrum Therapeutics upgraded to Outperform from Market Perform at Leerink
PremiumThe Fly
Fulcrum Therapeutics upgraded to Outperform from Market Perform at Leerink
5M ago
FULC
Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
5M ago
C
AA
Cantor upgrades Fulcrum to Overweight on sickle cell opportunity
PremiumThe FlyCantor upgrades Fulcrum to Overweight on sickle cell opportunity
5M ago
FULC
Fulcrum Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
Premium
The Fly
Fulcrum Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
5M ago
FULC
Oppenheimer biotech analyst holds an analyst/industry conference call
Premium
The Fly
Oppenheimer biotech analyst holds an analyst/industry conference call
5M ago
FULC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >